MWNA
CFMS

Marshall Wace North America’s Conformis, Inc. Common Stock CFMS Stock Holding History

Marshall Wace North America’s Portfolio CFMS Stock Details CFMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$366K Sell
11,028
-55,049
-83% -$1.94M ﹤0.01% 1198
2021
Q2 		$1.9M Buy
66,077
+14,956
+29% +$353K 0.01% 825
2021
Q1 		$1.26M Buy
+51,121
New +$1.38M 0.01% 962
2017
Q3 		– Sell
-875
Closed -$87K – 1584
2017
Q2 		$87K Buy
+875
New +$105K ﹤0.01% 1258

Other funds holding CFMS

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Marshall Wace North America's CFMS Position: Q3 2021 in Review

Marshall Wace North America reduced its Conformis, Inc. Common Stock (CFMS) stake by 83% in Q3 2021, selling an estimated $1.94M and leaving 11,028 shares worth $366K. The position accounts for ﹤0.01% of the portfolio, ranked #1198.

Marshall Wace North America first reported a position in CFMS in Q2 2017 and has held it in 4 quarters since. The position peaked at $1.9M in Q2 2021. 80 funds tracked by Wall St. Rank hold CFMS as of Q3 2021.

  • Marshall Wace North America held 11,028 shares of Conformis, Inc. Common Stock worth $366K as of Q3 2021.
  • Marshall Wace North America sold 55,049 Conformis, Inc. Common Stock shares in Q3 2021, an estimated $1.94M.
  • Conformis, Inc. Common Stock made up ﹤0.01% of Marshall Wace North America's portfolio in Q3 2021, its #1198 holding.
  • Marshall Wace North America first reported a position in Conformis, Inc. Common Stock in Q2 2017 and has held it in 4 quarters since.
  • Marshall Wace North America's Conformis, Inc. Common Stock position peaked at $1.9M in Q2 2021.
  • 80 funds tracked by Wall St. Rank held Conformis, Inc. Common Stock as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.